Sun Pharma Share Price Target 2025 to 2040 {update}

Company Details

• Founded: 1983
• Headquarters: Mumbai, India
• Sector: Pharmaceuticals
• Global Presence: Over 100 countries
• Competitors: Dr. Reddy’s, Cipla, Lupin

Promoter Details

Sun Pharma Share Price Target 2024

Growth Drivers:

1. Expansion in specialty drugs and generics.
2. Focus on innovation and R&D.

• Minimum Target: ₹1,850
• Maximum Target: ₹1,950

Sun Pharma Share Price Target 2025

Key Catalysts:

1. Strong global growth in specialty products.
2. Rising demand for chronic and lifestyle disease treatments.

• Minimum Target: ₹2,000
• Maximum Target: ₹2,150

Sun Pharma Share Price Target 2026 to 2030

Sun Pharma Share Price Target 2035

With advancements in biotechnology and personalized medicine, Sun Pharma is poised for substantial growth by 2035.

• Minimum Target: ₹4,500
• Maximum Target: ₹5,000

Sun Pharma Share Price Target 2040

By 2040, Sun Pharma’s investments in innovation, market diversification, and R&D are expected to yield impressive returns.

• Minimum Target: ₹6,500
• Maximum Target: ₹7,500

Final Thoughts

Sun Pharma remains a strong contender for long-term investments due to its consistent innovation, robust global presence, and focus on high-demand healthcare segments.

Disclaimer: Always conduct thorough research or consult a financial advisor before investing in stocks. For more insights, visit moneyphobia.in!